Human microRNA hsa-miR-1231 suppresses hepatitis B virus replication by targeting core mRNA.

Area of Science:

• Hepatology
• Virology
• Molecular Biology

Background:

• Hepatitis B virus (HBV) infection remains a significant global health concern.
• MicroRNA (miRNA) dysregulation is implicated in various viral infections, including HBV.
• Identifying pathogen-specific miRNAs can offer novel therapeutic strategies.

Purpose of the Study:

• To identify specific miRNAs directly associated with HBV infection in hepatocytes.
• To investigate the role of these identified miRNAs in regulating HBV replication.

Main Methods:

• Utilized urokinase-type plasminogen activator (uPA)-severe combined immunodeficiency (SCID) mouse models engrafted with human hepatocytes.
• Inoculated mice with HBV-infected patient serum and analyzed miRNA profiles in liver tissues using a Toray 3D array system.
• Assessed the impact of miRNA modulation on HBV replication in HBV-transfected HepG2 cells.

Main Results:

• Four miRNAs (hsa-miR-486-3p, hsa-miR-1908, hsa-miR-675, and hsa-miR-1231) were found to be upregulated in HBV-infected mouse and human livers.
• These miRNAs are associated with immune response pathways, including chemokine and cytokine signaling.
• hsa-miR-1231, exhibiting homology with HBV core and HBx sequences, was most significantly upregulated and suppressed HBV replication upon overexpression in HepG2 cells.

Conclusions:

• A novel interaction between hsa-miR-1231 and HBV replication was identified.
• hsa-miR-1231 demonstrates potential as a therapeutic target for developing new strategies against HBV infection.
• miRNA profiling offers a promising approach for understanding and combating viral hepatitis.